Medical Advisory Council | The Cure Starts Now


CSN Medical Advisory Council

The purpose of the Medical Advisory Council is to review grant submissions to determine their relevance and application to the core mission of The Cure Starts Now. They act to monitor and determine the framework of the grant process and then evaluate submissions bi-annually based upon funding abilities determined by the board. Once approved, this council then makes recommendations based on budget ability to the Strategic Advisory Council for approval.

Gavin Baumgardner, DO, Chair

Gavin Baumgardner, DO completed his education at Ohio University College of Osteopathic Medicine with residency at Doctors Hospital. He is currently with Ohio Health in the capacity of an Internal Medicine Hospitalist. He is Chair of the CSN Medical Advisory Council.

Alberto Broniscer, MD

Alberto Broniscer, MD is an Associate Member of Oncology with St. Jude Children's Research Hospital in Memphis. He specializes in pediatric high-grade glioma research.

Shana Coley, MD, PhD

Shana Coley, MD, PhD, is Chief Resident for Anatomic Pathology at Columbia University Medical Center in New York City. Her thesis research at Emory University focused on transplantation immunology, following twelve years of basic research in microbiology and immunology.

Stewart Goldman, MD

Medical director, Neuro-oncology, Gus Foundation Chair of Neuro-oncology; Associate professor of Pediatrics, Northwestern University's Feinberg School of Medicine

Nicholas Joseph Gottardo, MB ChB, FRACP, PhD

Consultant Paediatric Oncologist & Senior Research Fellow, Princess Margaret Hospital for Children and Telethon Institute for Child Health Research, Perth, Western Australia, Australia

Cynthia Hawkins, MD, PhD

Dr. Hawkins is a paediatric neuropathologist at The Hospital for Sick Children (SickKids). Her practice involves both surgical and autopsy neuropathology and includes neuro-oncologic, neuromuscular and neurodevelopmental disease.

Daniel McPherson, PhD

Daniel McPherson, PhD studied organic chemistry and biochemistry at Auburn University before becoming a Staff Scientist at Oak Ridge National Laboratory for Nuclear Medicine. Then after taking a position as Health Science Administrator for the National Institutes of Health with input into the grant administration position, he then moved to Cincinnati where he now operates as Section Head of Radiochemistry for a local drug company.

Michelle Monje Deisseroth, MD, PhD

Dr. Monje is an assistant professor of Neurology and Neurological Sciences and, by courtesy, of Pediatrics, Pathology and Neurosurgery at Stanford University. She is a pediatric neuro-oncologist and developmental neurobiologist whose laboratory is focused on elucidating DIPG developmental origins and microenvironmental determinants of growth, as well as identifying therapeutic targets for DIPG and other pediatric high-grade gliomas.

Roger J. Packer, MD

Children's National Medical Center, Senior Vice President, Center for Neuroscience and Behavioral Medicine; Director, Brain Tumor Institute; Director, Daniel and Jennifer Gilbert Neurofibromatosis Institute; Principal Investigator, Center for Neuroscience Research (CNR); Children's Research Institute (CRI)